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Abstract – The authors have presented the selected aspects of the 
epidemiology of urinary retention. They characterised the acute 
urinary retention (when the person cannot urinate at all) and 
chronic (partial) urinary retention, taking into account the causes. 
They have discussed in more detail the urinary retention in wom-
en – despite the fact that it occurs less frequently than urinary 
retention in men, its (neurogenic and/or psychogenic) aetiology is 
more difficult to be diagnosed unequivocally. The authors have 
emphasised that psychogenic dysfunctions of the lower urinary 
tract are often triggered by a psychological factor in the patients 
with congenital nervous system defects, whose lower urinary tract 
functioning used to be correct, but might have been on the verge 
of neurological capacity. Nevertheless, in some cases anatomic 
changes or neurological deficiencies cannot be located and the 
treatment can be based only on symptoms. 
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Streszczenie – Autorzy przedstawili wybrane zagadnienia z epi-
demiologii zatrzymania moczu. Scharakteryzowali ostre ( całko-
wite) i przewlekłe (częściowe) zatrzymanie moczu uwzględniając 
przyczyny powstawania. Omówili  szczegółowiej zatrzymanie 
moczu u kobiet, choć wyraźnie rzadziej występujące niż u męż-
czyzn, to jednak często trudne  do jednoznacznego zdiagnozowa-
nia etiologii – neurogennej i/lub psychogennej. Podkreślili, że 
dysfunkcje psychogenne dolnych dróg moczowych, często ujaw-
niają się po zadziałaniu czynnika psychicznego u chorych z wa-
dami wrodzonymi układu nerwowego, u których funkcjonowanie 
dolnych dróg moczowych było prawidłowe, jednak prawdopo-
dobnie na granicy wydolności neurologicznej. Niekiedy jednak, 
nie udaje się odnaleźć widocznych zmian anatomicznych ani 
nieprawidłowości neurologicznych i leczenie może być wyłącznie 
objawowe. 
 
Słowa kluczowe - zatrzymanie moczy, epidemiologia, przyczyny. 
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I.  GENERAL CHARACTERISTICS 
 
he frequency of urinary retention increases with age 
for both the sexes. However, in women the ailment 
occurs 10 times less frequently. In men after 70 years 
of age, the problem occurs for around 10%, while after 80 
years old it rises to around 30% [1-4]. The most common 
cause of urinary retention is the progression of benign pros-
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tate enlargement accompanied by some unfavourable fac-
tors such as [5,6]: 
 Alcohol consumption, 
 Prostate changes, 
 Urinary system infections, 
 Excessive intake of liquid, 
 Undergoing surgery with general anaesthesia. 
 
It has to be emphasised that urinary retention may occur on 
any given stage of benign prostate enlargement, regardless 
of the prostate size or the intensity of symptoms in the low-
er urinary tract. If defining the triggering factor proves im-
possible, such urinary retention is deemed idiopathic. Other 
causes of urinary retention in men are: urethral stricture, 
foreign body in the bladder, bladder tamponade (clots fill-
ing the bladder), pelvic area traumas, neurological disor-
ders, and the use of some medications [3,4,7-10]. 
Alongside the acute (sudden) urinary retention, the phe-
nomenon of the so-called partial urinary retention is also 
described. As the benign prostate enlargement progresses, 
the enlarging prostate pressurises the urethra, causing the 
urethral resistance to rise beyond the detrusor’s capacity to 
perform its function. The bladder pressure rises and the 
urine is retained. This leads to the development of cysto-
celes, widened urinary tract caused by impaired urine flow, 
hydronephrosis, and, in consequence, renal failure [1,11-
13]. 
The slow progression of the disease leads to significant 
bladder enlargement and serious urostasis, called urinary 
retention. An additional symptom at this stage of the dis-
ease can be urinary incontinence, i.e. the so called paradox-
ical incontinence or overflow incontinence. In cases when 
further bladder enlargement is impossible, urine escapes 
the full bladder involuntarily, which can be wrongly inter-
preted by the patient as incontinence [1]. 
Other causes leading to urinary retention are [1,14-16]: 
 Increased alpha-adrenergic activity, which can be 
caused by: stress, low temperature, alpha-
adrenergic drugs used to combat cold, acute pros-
tatitis, infection, bladder overtension,  
 Decreased proportions of the stroma components to 
epithelium in the prostate tissue is observed in 
men with acute urinary retention (AUR). This 
phenomenon could explain the role of finasteride 
in the prevention of urinary retention, as the drug 
impacts the epithelial components of the prostate 
tissue, leading to the decreased volume of the 
prostate in the longer term, 
 Neurotransmitter expression disorder – here, a spe-
cial role is played by the decrease of non-
adrenergic, non-cholinergic neurotransmission 
(vasoactive intestinal peptide, neuropeptide Y),  
 prostatitis, during the development of which the 
more frequent occurrence of inflammatory infiltra-
tion in the prostates of men suffering from AUR. 
Histological features of prostatitis are also consid-
ered a risk factor of benign prostatic hyperplasia 
(BPH).  
In turn, the factors that contribute to the development of 
AUR are [11,12,17-19]: 
 postnatal perineal inflammation, 
 genital herpes, Bartholin's gland abscess, 
 acute urethral inflammation, vulvovaginitis, 
 detrusor underactivity or atony. 
The increased risk factors for acute urinary retention in 
those patients are urinary tract inflammations, bleeding, 
excessive fluid consumption and overflowing bladder, al-
cohol abuse [1,4]. 
 
II. THE AETIOLOGY OF ACUTE URINARY 
RETENTION (AUR) 
 
AUR is characterised by sudden, painful inability to 
empty the bladder. Painless AUR occurs rarely and is most 
often related to the pathology of the central nervous system. 
AUR can be divided into a provoked one and an intrinsic 
one [1]. 
AUR can be triggered by the following factors 
[1,4,7,11,12]:  
 a surgery with general or local anaesthesia;  
 excessive fluid intake; 
 excessively stretched bladder;  
 urinary tract infection;  
 prostatitis, alcohol intake;  
 taking medications with sympathicomimetic  or 
cholinolytic effects. 
In most cases, the triggering factor remains unknown and 
the AUR is deemed intrinsic.  
There are some mechanisms which can lead to acute uri-
nary retention [1,11,12]:  
 increased urethral resistance resulting from an ana-
tomic obstruction (urethral stricture, enlarged 
prostate, bladder tamponade); 
 increased urethral resistance resulting from a func-
tional obstruction (the overtension of urethral 
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smooth muscles caused by increased alpha-
adrenergic stimulation);  
 overtension of the bladder (immobilisation, consti-
pation, medications inhibiting the bladder’s ability 
to shrink); 
 neurogenic causes (e.g. diabetic cystopathy). 
III. THE AETIOLOGY OF CHRONIC URINARY 
RETENTION (CUR) 
 
If the cause of CUR is a bladder obstruction, the pressure 
generated by the detrusor during micturition is high and the 
urine flow is weak. After the micturition is finished, the 
bladder pressure is still high, which leads to the increase of 
the pressure and bilateral widening of the upper urinary 
tract. Extrarenal kidney failure might be developed. Pa-
tients suffering from detrusor underactivity or atony have 
large volumes of urine stored, but the bladder pressure re-
mains low (low-pressure urinary retention). Lower urinary 
tract symptoms (LUTS) are usually not intensified, espe-
cially in the early stages, until involuntary micturition at 
night occurs, triggered by lower urethral resistance and 
increased bladder pressure. This symptom is called over-
flow incontinence (ischuria paradoxa) [1,7,18,19]. 
 
IV. SYMPTOMS OF CHRONIC URINARY 
RETENTION 
 
Chronic urinary retention occurs as a result of storing a 
certain volume of urine after each bladder emptying. In 
order to confirm the CUR diagnosis, the constantly stored 
volume must exceed 300 ml (or 500 ml, according to some 
authors) and might reach several litres. Those affected 
might show no symptoms or observe releasing only small 
volumes of urine when urinating, as well as having prob-
lems to commence and retain micturition. Other symptoms 
include night urination (nocturia), overflow incontinence, 
palpable bladder (first with pain, and in the final stages of 
urinary retention – with no pain), and kidney failure symp-
toms. The intensity of LUTS is mild [1]. 
Differentiation 
The differentiation is usually easy. However, ailments 
such as diverticulitis, diverticular abscess, intestine perfora-
tion or ischemia, aortic aneurysm, may result in symptoms 
that are similar to urinary retention, and also can cause it. 
Therefore, patients require re-examination after catheterisa-
tion so that other diagnoses can be ruled out. Sporadically, 
an obese patient with kidney failure might be diagnosed as 
an AUR case [4]. 
 
V. URINARY RETENTION IN WOMEN 
 
The problem of urinary retention in women is much less 
frequent than in men and it is also caused by other aetiolog-
ical factors.  
One can divide the causes of women’s urinary retention 
into two basic groups: neurogenic and psychogenic.  
The neurogenic aetiology pertains to women at different 
ages and can be very diverse, depending on the cause that 
triggers the neurogenic micturition disorders.  
The psychogenic aetiology is the case almost exclusively 
for women under 25 and it remains unexplained in greater 
detail.  
Regardless of the cause, urinary retention always re-
quires precise diagnostics, which is difficult especially in 
the case of psychogenic aetiology. Urinary retention diag-
nostics must be comprehensive and based on the collected 
medical history data as well as on the clinical, neurological, 
endoscopic, radiologic, and urodynamic examinations. 
Usually, the test that is decisive for the diagnosis is the 
urodynamic one, which indicates one of the two main caus-
es of the retention – i.e. the detrusor muscle underactivity 
or overactivity of the sphincter apparatus causing a func-
tional bladder outlet obstruction. A frequent cause of par-
tial urinary retention in women is a habit of withholding 
micturition. This causes the external urethral sphincter to 
grow, causing a mechanical obstruction for the urine flow 
[11,12,20-22]. 
Neurogenic dysfunctions of the lower urinary tract might 
be caused by: congenital spinal defects, spinal cord or cau-
da equina damage, the pressure put on the spinal cord or 
spinal roots by tumours, intervertebral disc prolapse, spinal 
cord inflammations, neurological diseases damaging the 
neurolemma of peripheral nerves, or iatrogenic damage to 
the lower urinary tract innervation. They usually trigger one 
of the two aforementioned causes of urinary retention. The 
simultaneous occurrence of both the causes of neurogenic 
urinary retention is extremely infrequent and is related to a 
mixed aetiology. 
Psychogenic dysfunctions of the lower urinary tract are 
often activated after the psychological factor is triggered in 
the patients with congenital nervous system defects whose 
lower urinary tract worked fine, yet on the fringe of neuro-
logical capacity. Sometimes no anatomical changes or neu-
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rological defects are visible and the treatment can only be 
symptom-based [11,12]. 
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